926 results on '"Ghelardini, C"'
Search Results
2. Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis
3. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy
4. Efficacy of isothiocyanate-based compounds on different forms of persistent pain
5. Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry disease
6. Increase of neurofilament-H protein in sensory neurons in antiretroviral neuropathy: Evidence for a neuroprotective response mediated by the RNA-binding protein HuD
7. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide
8. Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy
9. The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy
10. Development and characterization of functionalized niosomes for brain targeting of dynorphin-B
11. PKC-mediated HuD–GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy
12. Retraction of “Acetyl-l-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy” [Neuroscience 167(4) (2010) 1168–1174]
13. P16-11 In search of sensitive safety biomarkers of peripheral neurotoxicity in the rat: a collaborative effort across industry and academia (IMI NeuroDeRisk project)
14. The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction
15. Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: Could it correlate with in vivo neuropathy?
16. St. John's wort reversal of meningeal nociception: A natural therapeutic perspective for migraine pain
17. Healthy Properties of a New Formulation of Pomegranate‐Peel Extract in Mice Suffering from Experimental Autoimmune Encephalomyelitis
18. Precision Medicine in Alzheimer’s Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity
19. Nicotine psychopharmacology in animals
20. The neuropathy-protective agent acetyl-l-carnitine activates protein kinase C-γ and MAPKs in a rat model of neuropathic pain
21. Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models
22. Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat
23. Allosteric modulation of α7 nicotinic acetylcholine receptors downregulates inflammatory mediators in glial cells and inhibits chemotherapy-induced neuropathic pain in mice
24. Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study
25. An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown
26. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice
27. AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram)
28. The reduction of food intake induced in mice by benzylamine and its derivatives
29. St. Johnʼs wort relieves pain in an animal model of migraine
30. DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer
31. Abdominal pain models: mechanisms and therapies and experimental models
32. New “drug-in cyclodextrin-in deformable liposomes” formulations to improve the therapeutic efficacy of local anaesthetics
33. Effect of pertussis toxin on baclofen- and diphenhydramine-induced amnesia
34. Pharmacological in vivo Test to Evaluate the Bioavailability of some St Johnʼs Wort Innovative Oral Preparations
35. Effects of the combination of β-hydroxy-β-methyl butyrate and R(+) lipoic acid in a cellular model of sarcopenia
36. Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels
37. (E)-3-Furan-2-yl- N- p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation
38. Caffeine induces central cholinergic analgesia
39. Protective effect of acetyl-L-carnitine on the apoptotic pathway of peripheral neuropathy
40. Methylamine-dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats
41. α-2 agonists induce amnesia through activation of the Gi-protein signalling pathway
42. Central Cholinergic Challenging of Migraine by Testing Second-Generation Anticholinesterase Drugs
43. Endogenous morphine modulates acute thermonociception in mice
44. Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache
45. Diphenhydramine-induced amnesia is mediated by Gi-protein activation
46. Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist
47. Enriched environment in multiple sclerosis-related pathology: the positive role in mice suffering from experimental autoimmune encephalomyelitis
48. ANTI-INFLAMMATORY AND VISCERAL PAIN RELIEVING EFFECTS OF AR170, A POTENT AND SELECTIVE A3 RECEPTOR AGONIST, IN A RAT MODEL OF COLITIS
49. DEPRESSIVE BEHAVIOUR INDUCED BY INHIBITION OF mKv1.1 POTASSIUM CHANNEL EXPRESSION BY ANTISENSE ODN
50. Presynaptic auto- and hetero-receptors in the cholinergic regulation of pain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.